http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0336192-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6816 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6816 |
| filingDate | 1989-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1990-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0336192-A3 |
| titleOfInvention | Diagnostic process and means for the diagnostic and treatment of immunological diseases |
| abstract | The invention relates to a method for diagnosingnhereditary and immunological diseasesnFluorescence measurement of biological substances by looking at thendiagnostic substance if its molecular weight is overn5000, with the condensation product ofnFlavoprotein with alpha lipoic acid, which after the addition ofnIodoacetamide and dialysis remain after distillation,nmarked or the substance to be diagnosed if younMolecular weight is less than about 5000, with the furthernReaction product of the distillation residue with anReaction solutionn1,4-bis (4-methyl-5-phenyl-2-oxazolyl) benzene and p-terphenylnin an organic solvent, maleic anhydridenis added, and after standing for several hours onnset about neutral pH and in the usual waynis cleaned, marked and then in the usual way, if necessary.nafter separation, the florescence measurement or which toninvestigating biological substance with thencorresponding labeled substance, if necessary undernRelease of the dye and, if necessary, transfer of thenDye added to the corresponding substance andnthen, if necessary after normal biochemical incubation, thenCarries out measurement, and means for performing thisnProcedure marked in this way and possibly in itselfnare isolated in the usual way and possibly built into cellsnas well as the use of these agents for the therapy ofnimmunological diseases caused by radiation innLymphocyte built-in, fluorescence-labeled biologicalnSubstance with light of the appropriate wavelength and kits fornthe diagnostic procedure. |
| priorityDate | 1988-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.